Alzheimer's trials

Grant to fund first clinical trials aimed at Alzheimer's prevention

 

The School of Medicine has received nearly $4.2 million from the Alzheimer’s Association to accelerate the launch of the first clinical trials to prevent the symptoms of Alzheimer’s disease. The award is the largest research grant in the history of the 32-year-old association.

Randall J. Bateman, MD, principal investigator of the grant and director of the Dominantly Inherited Alzheimer’s Network (DIAN) Therapeutic Trials Unit at Washington University, will lead the trials, which will determine if the disease can be halted or delayed before problems in memory and other brain functions become apparent.

The research will be conducted through the DIAN, an international research partnership focused on understanding inherited forms of Alzheimer’s. DIAN is headed by John C. Morris, MD, the Harvey A. and Dorismae Hacker Friedman Professor of Neurology. Bateman and Morris treat patients at Barnes-Jewish Hospital.

READ MORE